ScholarLens Back to search
2006•Hainan yixueRequires access

The Therapeutic Effect of CsA+MA Regimens on 11 Cases of Refractory Acute Nonlymphocytic Leukemia

Mingchun Wang

Open publisher page 0 citations

Abstract

Objective To study the therapeutic effect of the CsA+MA program in treatment refractoriness acute non-lymphocytic leukemia. Methods To analyze the therapeutic effect of the CsA+MA program in treatment 11 cases refractoriness acute non-lymphocytic leukemia. Results Of the 11 patients, 6 patients reached complete remission, 1 patient partial remission, the rate of complete remission is 54.5%, effective power is 63.6%. 4 patients were ineffective. Conclusions The CsA+MA program is effective in treatment refractoriness acute non-lymphocytic leukemia.

About this research paper

What this paper is about

Objective To study the therapeutic effect of the CsA+MA program in treatment refractoriness acute non-lymphocytic leukemia. Methods To analyze the therapeutic effect of the CsA+MA program in treatment 11 cases refractoriness acute non-lymphocytic leukemia. Results Of the 11 patients, 6 patients reached complete remission, 1 patient partial remission, the rate of complete remission is 54.5%, effective power is 63.6%. 4 patients were ineffective. Conclusions The CsA+MA program is effective in treatment refractoriness acute non-lymphocytic leukemia.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the therapeutic effect of the CsA+MA program in treatment refractoriness acute non-lymphocytic leukemia. Methods To analyze the therapeutic effect of the CsA+MA program in treatment 11 cases refractoriness acute non-lymphocytic leukemia. Results Of the 11 patients, 6 patients reached complete remission, 1 patient partial remission, the rate of complete remission is 54.5%, effective power is 63.6%. 4 patients were ineffective. Conclusions The CsA+MA program is effective in treatment refractoriness acute non-lymphocytic leukemia.

Key concepts: Medicine, Refractory (planetary science), Refractory period, Leukemia, Complete remission, Therapeutic effect, Acute lymphocytic leukemia, Acute leukemia

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The Therapeutic Effect of CsA+MA Regimens on 11 Cases of Refractory Acute Nonlymphocytic Leukemia — Research Paper | ScholarLens